Lord, Abbett & Co
MDCO

Lord, Abbett & Co’s Medicines Co MDCO Stock Holding History

Lord, Abbett & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-784,500
Closed -$30.3M – 1107
2013
Q4 		$30.3M Buy
784,500
+7,500
+1% +$268K 0.07% 419
2013
Q3 		$26M Sell
777,000
-618,996
-44% -$19.7M 0.06% 452
2013
Q2 		$42.9M Buy
+1,395,996
New +$46.7M 0.1% 296

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lord, Abbett & Co's MDCO Position: Q1 2014 in Review

Lord, Abbett & Co sold out of Medicines Co (MDCO) in Q1 2014, closing a stake of 784,500 shares — an estimated $30.3M sold.

Lord, Abbett & Co first reported a position in MDCO in Q2 2013 and held it in 3 quarters. The position peaked at $42.9M in Q2 2013. 166 funds tracked by Wall St. Rank hold MDCO as of Q1 2014.

  • Lord, Abbett & Co reported no remaining Medicines Co position as of Q1 2014 after selling out during the quarter.
  • Lord, Abbett & Co sold 784,500 Medicines Co shares in Q1 2014, an estimated $30.3M.
  • Lord, Abbett & Co first reported a position in Medicines Co in Q2 2013 and held it in 3 quarters.
  • Lord, Abbett & Co's Medicines Co position peaked at $42.9M in Q2 2013.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q1 2014.

Based on Lord, Abbett & Co's 13F filing for Q1 2014, filed 15 May 2014.